Cara Therapeutic Stock Alpha and Beta Analysis
| CARA Stock | USD 0.29 0.01 3.33% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cara Therapeutic. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cara Therapeutic over a specified time horizon. Remember, high Cara Therapeutic's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cara Therapeutic's market risk premium analysis include:
Beta 1.12 | Alpha (0.42) | Risk 4.46 | Sharpe Ratio (0.04) | Expected Return (0.20) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Cara |
Cara Therapeutic Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cara Therapeutic market risk premium is the additional return an investor will receive from holding Cara Therapeutic long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cara Therapeutic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cara Therapeutic's performance over market.| α | -0.42 | β | 1.12 |
Cara Therapeutic expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cara Therapeutic's Buy-and-hold return. Our buy-and-hold chart shows how Cara Therapeutic performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cara Therapeutic Market Price Analysis
Market price analysis indicators help investors to evaluate how Cara Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cara Therapeutic shares will generate the highest return on investment. By understating and applying Cara Therapeutic stock market price indicators, traders can identify Cara Therapeutic position entry and exit signals to maximize returns.
Cara Therapeutic Return and Market Media
The median price of Cara Therapeutic for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 0.29 with a coefficient of variation of 10.19. The daily time series for the period is distributed with a sample standard deviation of 0.03, arithmetic mean of 0.3, and mean deviation of 0.02. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Wall Street SWOT Cara Therapeutics stock navigates pivotal phase in drug development - Investing.com | 09/27/2024 |
2 | Disposition of 2483 shares by Scott Terrillion of Cara Therapeutic at 3.51 subject to Rule 16b-3 | 10/28/2024 |
3 | Disposition of 3668 shares by Christopher Posner of Cara Therapeutic at 0.29 subject to Rule 16b-3 | 11/04/2024 |
4 | Cara Therapeutics CEO Posner sells shares worth 1,063 | 11/06/2024 |
5 | Cara Q3 Earnings Snapshot | 11/15/2024 |
About Cara Therapeutic Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cara or other stocks. Alpha measures the amount that position in Cara Therapeutic has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 18.26 | 38.82 | 69.93 | 66.43 | PTB Ratio | 2.72 | 3.63 | 0.7 | 0.67 |
Cara Therapeutic Upcoming Company Events
As portrayed in its financial statements, the presentation of Cara Therapeutic's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cara Therapeutic's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cara Therapeutic's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cara Therapeutic. Please utilize our Beneish M Score to check the likelihood of Cara Therapeutic's management manipulating its earnings.
| 4th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Cara Therapeutic
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Cara Therapeutic Backtesting, Cara Therapeutic Valuation, Cara Therapeutic Correlation, Cara Therapeutic Hype Analysis, Cara Therapeutic Volatility, Cara Therapeutic History and analyze Cara Therapeutic Performance. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Cara Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.